Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

Gary H. Lyman, Kari Bohlke, Alok A. Khorana et al. · Journal of Clinical Oncology · 2015 · 1.4K citations · Full text

Medicine, Hematology, Surgery +17

A comprehensive pathway map of epidermal growth factor receptor signaling

Kanae Oda, Yukiko Matsuoka, Akira Funahashi et al. · Molecular Systems Biology · 2005 · 1.2K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines

Mario Mandalà, Anna Falanga, Fausto Roila · Annals of Oncology · 2011 · 516 citations · Full text

Medicine, Hematology, Oncology +16

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

Brent C. Behrens, Thomas C. Hamilton, Hidetaka Masuda et al. · PubMed · 1987 · 500 citations

Medicine, Oncology, Pharmacology +17

A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer

H.Ş. Çoşkun, Özlem Er, Metin Özkan et al. · Journal of Thrombosis and Haemostasis · 2004 · 456 citations

Medicine, Oncology, Pharmacology +10